157 related articles for article (PubMed ID: 38037430)
21. Lenacapavir and the novel HIV-1 capsid inhibitors: an emerging therapy in the management of multidrug-resistant HIV-1 virus.
Lee NE; Sutherland RK
Curr Opin Infect Dis; 2023 Feb; 36(1):15-19. PubMed ID: 36753704
[TBL] [Abstract][Full Text] [Related]
22. Cell Type-Dependent Escape of Capsid Inhibitors by Simian Immunodeficiency Virus SIVcpz.
Twizerimana AP; Scheck R; Becker D; Zhang Z; Wammers M; Avelar L; Pflieger M; Häussinger D; Kurz T; Gohlke H; Münk C
J Virol; 2020 Nov; 94(23):. PubMed ID: 32907979
[TBL] [Abstract][Full Text] [Related]
23. Spatiotemporal binding of cyclophilin A and CPSF6 to capsid regulates HIV-1 nuclear entry and integration.
Ingram Z; Kline C; Hughson AK; Singh PK; Fischer HL; Sowd GA; Watkins SC; Kane M; Engelman AN; Ambrose Z
bioRxiv; 2024 Apr; ():. PubMed ID: 38645162
[TBL] [Abstract][Full Text] [Related]
24. Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.
Segal-Maurer S; DeJesus E; Stellbrink HJ; Castagna A; Richmond GJ; Sinclair GI; Siripassorn K; Ruane PJ; Berhe M; Wang H; Margot NA; Dvory-Sobol H; Hyland RH; Brainard DM; Rhee MS; Baeten JM; Molina JM;
N Engl J Med; 2022 May; 386(19):1793-1803. PubMed ID: 35544387
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 capsid stability enables inositol phosphate-independent infection of target cells and promotes integration into genes.
Sowd GA; Shi J; Fulmer A; Aiken C
PLoS Pathog; 2023 Jun; 19(6):e1011423. PubMed ID: 37267431
[TBL] [Abstract][Full Text] [Related]
26. Highlights on the Development, Related Patents, and Prospects of Lenacapavir: The First-in-Class HIV-1 Capsid Inhibitor for the Treatment of Multi-Drug-Resistant HIV-1 Infection.
Dzinamarira T; Almehmadi M; Alsaiari AA; Allahyani M; Aljuaid A; Alsharif A; Khan A; Kamal M; Rabaan AA; Alfaraj AH; AlShehail BM; Alotaibi N; AlShehail SM; Imran M
Medicina (Kaunas); 2023 May; 59(6):. PubMed ID: 37374245
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals.
Nka AD; Bouba Y; Teto G; Semengue ENJ; Takou DK; Ngueko AMK; Fabeni L; Carioti L; Armenia D; Pabo W; Dambaya B; Sosso SM; Colizzi V; Perno CF; Ceccherini-Silberstein F; Santoro MM; Fokam J; Ndjolo A
J Antimicrob Chemother; 2022 Dec; 78(1):272-275. PubMed ID: 36411257
[TBL] [Abstract][Full Text] [Related]
28. The Cleavage and Polyadenylation Specificity Factor 6 (CPSF6) Subunit of the Capsid-recruited Pre-messenger RNA Cleavage Factor I (CFIm) Complex Mediates HIV-1 Integration into Genes.
Rasheedi S; Shun MC; Serrao E; Sowd GA; Qian J; Hao C; Dasgupta T; Engelman AN; Skowronski J
J Biol Chem; 2016 May; 291(22):11809-19. PubMed ID: 26994143
[TBL] [Abstract][Full Text] [Related]
29. Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins.
Kobayakawa T; Yokoyama M; Tsuji K; Boku S; Kurakami M; Fujino M; Ishii T; Miura Y; Nishimura S; Shinohara K; Yamamoto K; Bolah P; Kotani O; Murakami T; Sato H; Tamamura H
Chem Pharm Bull (Tokyo); 2024; 72(1):41-47. PubMed ID: 38171903
[TBL] [Abstract][Full Text] [Related]
30. HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules.
Saito A; Yamashita M
Retrovirology; 2021 Oct; 18(1):32. PubMed ID: 34702294
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 capsid stability and reverse transcription are finely balanced to minimize sensing of reverse transcription products
Eschbach JE; Puray-Chavez M; Mohammed S; Wang Q; Xia M; Huang L-C; Shan L; Kutluay SB
mBio; 2024 May; 15(5):e0034824. PubMed ID: 38530034
[TBL] [Abstract][Full Text] [Related]
32. Resistance Analyses in Highly Treatment-Experienced People With Human Immunodeficiency Virus (HIV) Treated With the Novel Capsid HIV Inhibitor Lenacapavir.
Margot NA; Naik V; VanderVeen L; Anoshchenko O; Singh R; Dvory-Sobol H; Rhee MS; Callebaut C
J Infect Dis; 2022 Nov; 226(11):1985-1991. PubMed ID: 36082606
[TBL] [Abstract][Full Text] [Related]
33. Cytoplasmic CPSF6 Regulates HIV-1 Capsid Trafficking and Infection in a Cyclophilin A-Dependent Manner.
Zhong Z; Ning J; Boggs EA; Jang S; Wallace C; Telmer C; Bruchez MP; Ahn J; Engelman AN; Zhang P; Watkins SC; Ambrose Z
mBio; 2021 Mar; 12(2):. PubMed ID: 33758083
[TBL] [Abstract][Full Text] [Related]
34. HIV-1 Maturation: Lessons Learned from Inhibitors.
Kleinpeter AB; Freed EO
Viruses; 2020 Aug; 12(9):. PubMed ID: 32858867
[TBL] [Abstract][Full Text] [Related]
35. Multiple Pathways To Avoid Beta Interferon Sensitivity of HIV-1 by Mutations in Capsid.
Sultana T; Mamede JI; Saito A; Ode H; Nohata K; Cohen R; Nakayama EE; Iwatani Y; Yamashita M; Hope TJ; Shioda T
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511380
[TBL] [Abstract][Full Text] [Related]
36. Pharmacologic hyperstabilisation of the HIV-1 capsid lattice induces capsid failure.
Faysal KMR; Walsh JC; Renner N; Márquez CL; Shah VB; Tuckwell AJ; Christie MP; Parker MW; Turville SG; Towers GJ; James LC; Jacques DA; Böcking T
Elife; 2024 Feb; 13():. PubMed ID: 38347802
[TBL] [Abstract][Full Text] [Related]
37. Visualizing HIV-1 Capsid and Its Interactions with Antivirals and Host Factors.
Wilbourne M; Zhang P
Viruses; 2021 Feb; 13(2):. PubMed ID: 33557422
[TBL] [Abstract][Full Text] [Related]
38. A Novel Phenotype Links HIV-1 Capsid Stability to cGAS-Mediated DNA Sensing.
Siddiqui MA; Saito A; Halambage UD; Ferhadian D; Fischer DK; Francis AC; Melikyan GB; Ambrose Z; Aiken C; Yamashita M
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167922
[TBL] [Abstract][Full Text] [Related]
39. Capsid-CPSF6 Interaction Licenses Nuclear HIV-1 Trafficking to Sites of Viral DNA Integration.
Achuthan V; Perreira JM; Sowd GA; Puray-Chavez M; McDougall WM; Paulucci-Holthauzen A; Wu X; Fadel HJ; Poeschla EM; Multani AS; Hughes SH; Sarafianos SG; Brass AL; Engelman AN
Cell Host Microbe; 2018 Sep; 24(3):392-404.e8. PubMed ID: 30173955
[TBL] [Abstract][Full Text] [Related]
40. Prion-like low complexity regions enable avid virus-host interactions during HIV-1 infection.
Wei G; Iqbal N; Courouble VV; Francis AC; Singh PK; Hudait A; Annamalai AS; Bester S; Huang SW; Shkriabai N; Briganti L; Haney R; KewalRamani VN; Voth GA; Engelman AN; Melikyan GB; Griffin PR; Asturias F; Kvaratskhelia M
Nat Commun; 2022 Oct; 13(1):5879. PubMed ID: 36202818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
